StocksDeepDive
Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC

XFOR — X4 Pharmaceuticals, Inc.

UNDERVALUED (MOS +83.5%) · Quality 18/100

Price
3.58
Intrinsic value
21.74
Margin of safety
+83.5%
Implied growth (reverse DCF)
-
a described calculation from stated inputs, not a forecast
Value Score
28.8
Quality
18
Psychology
21.1
Discovery
19.3
price/volume attention only
Moat score
18
erosion: none

Value Score: bottom 45% of Russell 3000 · Quality: bottom 10%

Open the interactive Deep Dive for XFOR →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/XFOR - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is XFOR undervalued?

As of 2026-09-19, XFOR trades at 3.58 against a computed intrinsic value of 21.74 (+83.5% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is X4 Pharmaceuticals, Inc.'s Value Score?

X4 Pharmaceuticals, Inc.'s Value Score is 28.8 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.